References
- Bobitt JR, Ledger WJ. 1978. Amniotic fluid analysis. Its role in maternal neonatal infection. Obstetrics and Gynecology 51:56–62.
- Cobo T, Palacio M, Martinez-Terron M, Navarro-Sastre A, Bosch J, Filella X et al. 2011. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 205: 126e121–e128.
- Garry D, Figueroa R, Aguero-Rosenfeld M, Martinez E, Visintainer P, Tejani N. 1996. A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery. American Journal of Obstetrics and Gynecology 175: 1336–1341.
- Genc MR, Ford CE. 2010. The clinical use of inflammatory markers during pregnancy. Current Opinions in Obstetrics and Gynecology 22:116–121.
- Goldenberg RL, Culhane JF, Iams JD, Romero R. 2008. Epidemiology and causes of preterm birth. Lancet 371:75–84.
- Goldenberg RL, Hauth JC, Andrews WW. 2000. Intrauterine infection and preterm delivery. New England Journal of Medicine 342:1500–1507.
- Gomez R, Romero R, Galasso M, Behnke E, Insunza A, Cotton DB. 1994. The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. American Journal of Reproductive Immunology 32:200–210.
- Yoon BH, Jun JK, Park KH, Syn HC, Gomez R, Romero R. 1996. Serum C- reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstetrics and Gynecology 88:1034–1040.